top of page
About Us
CEO 인사말
기업 연혁
오시는 길
R&D
핵심 기술
연구 성과
Pipeline
IMB001
IMB002
IR/PR
공지사항
보도자료
Career
채용안내
인재상
복리후생
< Back
A new study by ImmunoBiome-POSTECH research team identifies new drug candidate targeting multiple sclerosis and inflammatory bowel disease
Microbiome Times
Previous
Next
bottom of page
